药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Brompheniramine
Secukinumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Secukinumab.
Brompheniramine
Certolizumab pegol
The risk or severity of adverse effects can be increased when Budesonide is combined with Certolizumab pegol.
Brompheniramine
Golimumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Golimumab.
Brompheniramine
Rilonacept
The risk or severity of adverse effects can be increased when Budesonide is combined with Rilonacept.
Brompheniramine
Tocilizumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Tocilizumab.
Brompheniramine
Canakinumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Canakinumab.
Brompheniramine
Apremilast
The risk or severity of adverse effects can be increased when Budesonide is combined with Apremilast.
Brompheniramine
Afelimomab
The risk or severity of adverse effects can be increased when Budesonide is combined with Afelimomab.
Brompheniramine
Colchicine
The risk or severity of adverse effects can be increased when Budesonide is combined with Colchicine.
Brompheniramine
Abatacept
The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept.
Brompheniramine
Vilanterol
The risk or severity of adverse effects can be increased when Budesonide is combined with Vilanterol.
Brompheniramine
Temozolomide
The risk or severity of adverse effects can be increased when Temozolomide is combined with Budesonide.
Brompheniramine
Tetrandrine
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Budesonide.
Brompheniramine
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Budesonide.
Brompheniramine
Bleselumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Bleselumab.
Brompheniramine
Rozanolixizumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Rozanolixizumab.
Brompheniramine
Risankizumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Risankizumab.
Brompheniramine
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Budesonide is combined with Monomethyl fumarate.
Brompheniramine
Begelomab
The risk or severity of adverse effects can be increased when Budesonide is combined with Begelomab.
Brompheniramine
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Budesonide is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.